Eton Pharmaceuticals Inc. (NASDAQ: ETON) reported Q1 EPS of $0.19, versus ($0.50) reported last year. Revenue for the quarter came in at $11.9 million, versus $99 thousand reported last year.

For earnings history and earnings-related data on Eton Pharmaceuticals Inc. (ETON) click here.